UNSPSC 51162623: Dibunate

This classification denotes a cough suppressant with the molecular formula C18H24O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZXY319VL5S, chemically known as 1-naphthalenesulfonic acid, 3,6-bis(1,1-dimethylethyl)-, ethyl ester or 2,6-ditert-butylnaphthalene-1-sulfonic acid but more generally known as dibunate, which bears US NIH Compound Identifier 3084737. European Medicines Agency schedules dibunate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10557MIG.

The term dibunate is an International Non-Proprietary Name or INN. As of Q4 2014, DIBUNATE remains US FDA's Preferred Term for this commodity. SMILES: CC(C)(C)C1=CC2=C(C=C1)C(=C(C=C2)C(C)(C)C)S(=O)(=O)O.

UNSPSC 51162623 Dibunate is a Commodity code that describes pharmaceutical and medical products state and local governments are procuring for public health, community health, and emergency response initiatives. Recent solicitations under this code show state and local buyers acquiring naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products for distribution through county health departments, cooperative purchasing alliances, and authorized wholesaler networks. Issuing bodies include county health departments and state-level cooperative purchasing organizations; Seminole County, Florida and the Minnesota Department of Administration's Office of State Procurement (administering MMCAP) appear as recent active buyers. The work involves supplying branded and generic pharmaceutical products with full compliance to FDA requirements, current Good Manufacturing Practices (cGMP), and the Drug Supply Chain Security Act (DSCSA), with vendors expected to maintain contractual relationships with authorized wholesalers and establish pricing through multiple formats including fixed price, net price, and WAC-minus structures.

Geographic activity centers on Florida and Minnesota, with interstate reach through cooperative purchasing vehicles that extend to participating states including Oregon. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building, with bid responses due July 26, 2023. The Minnesota Department of Administration issued RFP S1070000015802 on January 20, 2026, through MMCAP to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with proposals due March 26, 2026 and awarded products effective July 1, 2026. Vendors must carry comprehensive insurance including workers' compensation, commercial general liability, network security and privacy liability, and professional liability; demonstrate cGMP and DSCSA compliance; and accept a 3 percent administrative fee on all contract purchases for MMCAP awards.